TEL AVIV, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) -- . (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that ...
About NeuroThera Labs Inc. NeuroThera is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions ...
The demonstration represents another development milestone in the Company’s development of quantum-enabled platform for high-dimensional clinical ...
Defense News on MSN
Has the Pentagon given up on AI polygraph analysis of loyalty?
AI-aided scanning of speech patterns, vocal stress or facial expressions to read minds lacks scientific backing and will ...
Researchers have developed REBOSEP, a computational workflow that maps gene expression as a continuous signal across tissue ...
AI-aided scanning of speech patterns, vocal stress or facial expressions to read minds lacks scientific backing and will ...
Today's QuestionWhen AI can read data, perform analysis, and provide answers, what will human analysts design and ...
Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that it will share nine new data presentations, including five oral presentations, at the American Society of Nephrology (ASN) Kidney Week ...
A large part of urban planning involves navigating how people experience a place. That kind of insight can require collecting data at a level of detail that large-scale datasets cannot provide.
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced new data evaluating the efficacy and safety of POMBILITI ® (cipaglucosidase alfa-atga) + OPFOLDA ® (miglustat) in late-onset Pompe disease ...
One of the strongest signals, albeit weaker than the original GWAS findings two decades ago, highlighted a novel regulatory ...
A post hoc analysis shows significant improvement in myasthenia gravis symptoms with telitacicept, achieving high rates of minimal symptom expression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results